Free Newsletter
AZ appeals $215M Medicaid verdict
Free newsletter via e-mail
Tools
AstraZeneca asked an Alabama judge to toss out or reduce a $215 million jury verdict in a Medicaid drug price fraud lawsuit, saying that the state didn't prove that AstraZeneca deliberately caused the Medicaid system to overpay for drugs. A ruling is expected within 10 days. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: